The Relationship Between Chronic Liver Disease and Osteoporosis: A Retrospective Single-Center Experience

ORIGINAL ARTICLE
Sarah Abdulkarim Alnemari, Sarah Mayudh Alrabie, Ruba Abdulrahman Alazwery, Shahad Abdullah Alzahrani, Amin Elzaki, Hamid Osman, Mona Elhaj, Ohud Alzahrani, Sahal Alotaibi, Amna Mohamed Ahmed, Mohamed Y. Hanfi, Mayeen Uddin Khandaker

 
For citation: Alnemari SA, Alrabie SM, Alazwery RA, Alzahrani SA, Elzaki A, Osman H, Elhaj M, Alzahrani O, Alotaibi S, Hanfi MY, Khandaker MU. The Relationship Between Chronic Liver Disease and Osteoporosis: A Retrospective Single-Center Experience. International Journal of Biomedicine. 2024;14(4):659-663. doi:10.21103/Article14(4)_OA20
 
Originally published December 5, 2024
 

Abstract: 

Background: Present evidence discussed in literature reviews shows that chronic liver disease (CLD) leads to an increased risk of osteoporosis. Our study aimed to investigate the association between CLD and bone mineral density (BMD), a key indicator of osteoporosis.
Methods and Results: This retrospective study included 53 patients (mean age of 63.7± 9.3 years) with CLD who underwent a DEXA scan at the lumbar spine and femoral neck. A majority (83.0%) of the patients were females. Overall, 22.6% of the patients were suffering from liver cirrhosis, 17.0% from hepatitis, and 60.4% had NAFLD. The mean T-scores for the femoral neck and lumbar spine were 1.67±1.07 and -2.43±1.11, respectively. Based on the T-scores, 47.2% of the patients had osteoporosis, and 41.5% had osteopenia. No statistically significant relationship was observed between BMD and liver disease (P=0.388).
Conclusion: Despite the high prevalence of osteoporosis (47.2%) and osteopenia (41.5%), no statistically significant changes in BMD were found among the study population with CLD. Adjustments for age, sex, and BMI did not help to identify a confirmed association between the diagnosis of CLD and osteoporosis in the study population. Further investigation is warranted to explore the potential association between specific CLD subtypes and osteoporosis risk.

Keywords: 
bone mineral density • chronic liver disease • cirrhosis • nonalcoholic fatty liver disease • osteoporosis
References: 
  1. Sharma A, Nagalli S. Chronic Liver Disease. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32119484.
  2. Muhsen IN, AlFreihi O, Abaalkhail F, AlKhenizan A, Khan M, Eldali A, Alsohaibani F. Bone mineral density loss in patients with cirrhosis. Saudi J Gastroenterol. 2018 Nov-Dec;24(6):342-347. doi: 10.4103/sjg.SJG_74_18. PMID: 29943736; PMCID: PMC6253916.
  3. Muzica CM, Sfarti C, Trifan A, Zenovia S, Cuciureanu T, Nastasa R, Huiban L, Cojocariu C, Singeap AM, Girleanu I, Chiriac S, Stanciu C. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Can J Gastroenterol Hepatol. 2020 Dec 28;2020:6638306. doi: 10.1155/2020/6638306. PMID: 33425804; PMCID: PMC7781697.
  4. Gokcan H, Kayhan MA, Demir SO, Kacar S, Cam P, Kaplan M, Daylak R, Oztuna D, Kuran SÖ, Ari D. Prevalence and characteristics of bone disease in cirrhotic patients. Hepatol Forum. 2020 May 21;1(2):48-52. doi: 10.14744/hf.2020.2020.0007. PMID: 35949442; PMCID: PMC9349342.
  5. Yang YJ, Kim DJ. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. Int J Mol Sci. 2021 Mar 5;22(5):2604. doi: 10.3390/ijms22052604. PMID: 33807573; PMCID: PMC7961345.
  6. Zheng JP, Miao HX, Zheng SW, Liu WL, Chen CQ, Zhong HB, Li SF, Fang YP, Sun CH. Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography. Medicine (Baltimore). 2018 May;97(20):e10645. doi: 10.1097/MD.0000000000010645. PMID: 29768330; PMCID: PMC5976349.
  7. Ranjan R, Rampal S, Jaiman A, Tokgöz MA, Koong JK, Ramayah K, Rajaram R. Common musculoskeletal disorders in chronic liver disease patients. Jt Dis Relat Surg. 2021;32(3):818-823. doi: 10.52312/jdrs.2021.25. Epub 2021 Nov 19. PMID: 34842121; PMCID: PMC8650659.
  8. Zhang Y, Gao X, Liu T, Gao P, Li H, Liu N, Gao L, Wan G, Zhang Y, Duan X. Association between osteoporosis and hepatitis B cirrhosis: a case-control study. Afr Health Sci. 2020 Dec;20(4):1610-1616. doi: 10.4314/ahs.v20i4.13. PMID: 34394221; PMCID: PMC8351827.
  9. Guañabens N, Parés A. Osteoporosis in chronic liver disease. Liver Int. 2018 May;38(5):776-785. doi: 10.1111/liv.13730. Epub 2018 Mar 25. PMID: 29479832.
  10. Chen K, Sng WK, Quah JH, Liu J, Chong BY, Lee HK, Wang XF, Tan NC, Chang PE, Tan HC, Bee YM, Goh GBB. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. PLoS One. 2020 Aug 21;15(8):e0236977. doi: 10.1371/journal.pone.0236977. PMID: 32822391; PMCID: PMC7446805.
  11. García-Compeán D, Orsi E, Kumar R, Gundling F, Nishida T, Villarreal-Pérez JZ, Del Cueto-Aguilera ÁN, González-González JA, Pugliese G. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World J Gastroenterol. 2022 Feb 28;28(8):775-793. doi: 10.3748/wjg.v28.i8.775. PMID: 35317103; PMCID: PMC8900578.
  12. Jeong HM, Kim DJ. Bone Diseases in Patients with Chronic Liver Disease. Int J Mol Sci. 2019 Aug 31;20(17):4270. doi: 10.3390/ijms20174270. PMID: 31480433; PMCID: PMC6747370.
  13. Kamel SH. Effect of fatty liver disease on bone density. ClinicalTrials.gov. 2021. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT04850547
  14. Shateri K, Vousoghian S, Oshnoei S, Mohammadi A. Association of osteoporosis with non-alcoholic fatty liver disease in adults. J Adv Pharm Edu Res. 2019;9(2):51-7.
  15. Nazir H, Chachar AZK, Khan MJ, Abaidullah S. Frequency of osteoporosis in patients of chronic liver disease. Pak J Med Health Sci. 2019;13(4):717-9.
  16. Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res. 2018 Oct;48(11):893-904. doi: 10.1111/hepr.13192. Epub 2018 Jun 1. PMID: 29734510.
  17. Xie R, Liu M. Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density. Front Endocrinol (Lausanne). 2022 Mar 14;13:857110. doi: 10.3389/fendo.2022.857110. PMID: 35360054; PMCID: PMC8964007.
  18. Ciardullo S, Muraca E, Zerbini F, Manzoni G, Perseghin G. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2856-e2865. doi: 10.1210/clinem/dgab262. PMID: 33878156.
  19. Du YJ, Liu NN, Zhong X, Pan TR. Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations. Diabetes Metab Syndr Obes. 2022 Jun 21;15:1925-1934. doi: 10.2147/DMSO.S364804. PMID: 35761888; PMCID: PMC9233539.

Download Article
Received October 14, 2024.
Accepted November 22, 2024.
©2024 International Medical Research and Development Corporation.